310 related articles for article (PubMed ID: 18679822)
1. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
[TBL] [Abstract][Full Text] [Related]
2. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
[TBL] [Abstract][Full Text] [Related]
3. Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.
Alsharhan H; Ng BG; Daniel EJP; Friedman J; Pivnick EK; Al-Hashem A; Faqeih EA; Liu P; Engelhardt NM; Keller KN; Chen J; Mazzeo PA; ; Rosenfeld JA; Bamshad MJ; Nickerson DA; Raymond KM; Freeze HH; He M; Edmondson AC; Lam C
J Inherit Metab Dis; 2021 Jul; 44(4):987-1000. PubMed ID: 33583022
[TBL] [Abstract][Full Text] [Related]
4. CDG-Id in two siblings with partially different phenotypes.
Kranz C; Sun L; Eklund EA; Krasnewich D; Casey JR; Freeze HH
Am J Med Genet A; 2007 Jul; 143A(13):1414-20. PubMed ID: 17551933
[TBL] [Abstract][Full Text] [Related]
5. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features.
Weinstein M; Schollen E; Matthijs G; Neupert C; Hennet T; Grubenmann CE; Frank CG; Aebi M; Clarke JT; Griffiths A; Seargeant L; Poplawski N
Am J Med Genet A; 2005 Jul; 136(2):194-7. PubMed ID: 15945070
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.
Paketci C; Edem P; Hiz S; Sonmezler E; Soydemir D; Sarikaya Uzan G; Oktay Y; O'Heir E; Beltran S; Laurie S; Töpf A; Lochmuller H; Horvath R; Yis U
Brain Dev; 2020 Aug; 42(7):539-545. PubMed ID: 32389449
[TBL] [Abstract][Full Text] [Related]
7. ALG11-CDG syndrome: Expanding the phenotype.
Haanpää MK; Ng BG; Gallant NM; Singh KE; Brown C; Kimonis V; Freeze HH; Muller EA
Am J Med Genet A; 2019 Mar; 179(3):498-502. PubMed ID: 30676690
[TBL] [Abstract][Full Text] [Related]
8. Novel variants and clinical symptoms in four new ALG3-CDG patients, review of the literature, and identification of AAGRP-ALG3 as a novel ALG3 variant with alanine and glycine-rich N-terminus.
Himmelreich N; Dimitrov B; Geiger V; Zielonka M; Hutter AM; Beedgen L; Hüllen A; Breuer M; Peters V; Thiemann KC; Hoffmann GF; Sinning I; Dupré T; Vuillaumier-Barrot S; Barrey C; Denecke J; Kölfen W; Düker G; Ganschow R; Lentze MJ; Moore S; Seta N; Ziegler A; Thiel C
Hum Mutat; 2019 Jul; 40(7):938-951. PubMed ID: 31067009
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
[TBL] [Abstract][Full Text] [Related]
12. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie).
Kim S; Westphal V; Srikrishna G; Mehta DP; Peterson S; Filiano J; Karnes PS; Patterson MC; Freeze HH
J Clin Invest; 2000 Jan; 105(2):191-8. PubMed ID: 10642597
[TBL] [Abstract][Full Text] [Related]
13. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
14. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.
Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L
Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421
[TBL] [Abstract][Full Text] [Related]
15. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
16. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.
Morava E; Vodopiutz J; Lefeber DJ; Janecke AR; Schmidt WM; Lechner S; Item CB; Sykut-Cegielska J; Adamowicz M; Wierzba J; Zhang ZH; Mihalek I; Stockler S; Bodamer OA; Lehle L; Wevers RA
Pediatrics; 2012 Oct; 130(4):e1034-9. PubMed ID: 22966035
[TBL] [Abstract][Full Text] [Related]
17. Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG.
van Tol W; Michelakakis H; Georgiadou E; van den Bergh P; Moraitou M; Papadimas GK; Papadopoulos C; Huijben K; Alsady M; Willemsen MA; Lefeber DJ
J Inherit Metab Dis; 2019 Sep; 42(5):984-992. PubMed ID: 30931530
[TBL] [Abstract][Full Text] [Related]
18. Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip.
Thiel C; Rind N; Popovici D; Hoffmann GF; Hanson K; Conway RL; Adamski CR; Butler E; Scanlon R; Lambert M; Apeshiotis N; Thiels C; Matthijs G; Körner C
Hum Mutat; 2012 Mar; 33(3):485-7. PubMed ID: 22213132
[TBL] [Abstract][Full Text] [Related]
19. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
[TBL] [Abstract][Full Text] [Related]
20. ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.
Farolfi M; Cechova A; Ondruskova N; Zidkova J; Kousal B; Hansikova H; Honzik T; Liskova P
BMC Ophthalmol; 2021 Jun; 21(1):249. PubMed ID: 34090370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
